Prevalence and management of abdominal cramping and pain: A multinational survey

Alimentary Pharmacology and Therapeutics

Volumn 24, Issue 2, 2006, Pages 411-419

  Quigley, E M M ^a   Locke, G R ^b   Mueller Lissner, S ^c   Paulo, L G ^d   Tytgat, G N ^e   Helfrich, I ^f   Schaefer, E ^f  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b MAYO CLINIC   (United States)

^c HUMBOLDT UNIVERSITY   (Germany)

^d Academia de Medicina do Rio de Janeiro   (Brazil)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTACID AGENT; ANTIDIARRHEAL AGENT; ANTIEMETIC AGENT; GASTROINTESTINAL AGENT; NON PRESCRIPTION DRUG; SPASMOLYTIC AGENT;

ABDOMINAL CRAMP; ABDOMINAL PAIN; AGE; ARTICLE; BRAZIL; CENTRAL AMERICA; COMMUNITY CARE; DEMOGRAPHY; DISEASE SEVERITY; GASTROINTESTINAL TRACT FUNCTION; GERMANY; HEALTH SURVEY; HUMAN; INTERVIEW; JAPAN; MARKETING; MEXICO; PREVALENCE; PRIORITY JOURNAL; SOUTH AMERICA; SYMPTOMATOLOGY; UNITED KINGDOM; UNITED STATES;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; COLIC; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE;

EID: 33745672272     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.02989.x     Document Type: Article

References (16)

1. Bommelaer G, Poynard T, Le Pen C, et al. Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria. Gastroenterol Clin Biol 2004; 28: 554-61.
2. Sandler RS, Stewart WF, Liberman JN, Ricci JA, Zorich NL. Abdominal pain, bloating, and diarrhea in the United States: prevalence and impact. Dig Dis Sci 2000; 45: 1166-71.
3. Kruis W, Thieme C, Weinzierl M, et al. A diagnostic score for the irritable bowel syndrome. Gastroenterology 1984; 87: 1-7.
4. Drossman DA, Li Z, Andruzzi E, et al. US householder survey of functional gastrointestinal disorders: prevalence, sociodemography, and health impact. Dig Dis Sci 1993; 38: 1569-80.
5. Talley NJ. Irritable bowel syndrome: definition, diagnosis and epidemiology. Clin Gastroenterol 1999; 13: 371-84.
6. Jones R, Lydeard S. Irritable bowel syndrome in the general population. Br Med J 1991; 304: 87-90.
7. Weber FH, McCallum RW. Clinical approaches to irritable bowel syndrome. Lancet 1992; 340: 1447-52.
8. Manning AP, Thompson WG, Heaton KE, Morris AF. Towards positive diagnosis of the irritable bowel. Br Med J 1978; 2: 653-4.
9. Drossman DA, Richter JE, Talley NJ, et al. The Functional Gastrointestinal Disorders, Pathophysiology and Treatment - a Multinational Consensus. Boston, USA: Little Brown and Co., 1994.
10. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lisner SA. Functional bowel disorders and functional abdominal pain. Gut 1999; 45: 1143-7.
11. Hungin APS, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects. Aliment Pharmacol Ther 2003; 17: 643-50.
12. Cash BD, Chey WD. Review article: Irritable bowel syndrome - an evidence-based approach to diagnosis. Aliment Pharmacol Ther 2004; 19: 1235-45.
13. Mearin F, Badia X, Balboa A, et al. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in the general population. Scand J Gastroenterol 2001; 36: 1155-61.
14. Hillilä MT, Färkkilä MA. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population. Aliment Pharmacol Ther 2004; 20: 339-45.
15. Wilson S, Roberts L, Roalfe A, Bridge P, Singh S. Prevalence of irritable bowel syndrome: a community survey. Br J Clin Pract 2004; 54: 495-502.
16. Chang L. Review article: Epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther 2004; 20 (Suppl. 7): 31-9.